America’s fisheries are among the world’s richest in abundance and diversity. They provide scientific, aesthetic, recreational, commercial, subsistence, cultural, social, and economic benefits. FAC leads aquatic resource management for the Service and strives to invest its resources in the nation’s highest priority aquatic conservation and water-based recreational needs. Fish health is a critical component of healthy fisheries and core to the work of the Fish and Aquatic Conservation Program.
The Aquatic Animal Drug Approval Partnership (AADAP) program is part of the Fish and Aquatic Conservation fish health work. It is the only program in the United States singularly dedicated to obtaining U.S. Food and Drug Administration (FDA) approval of new medications needed for use in fish culture and fisheries management. Since the late 1990’s, AADAP has contributed to virtually every new fish medication approved by the FDA. Ultimately, the AADAP program allows fisheries professionals to more effectively and efficiently rear and manage a variety of fish species to meet production goals, stock healthy fish, and maintain a healthy environment.
We hope everyone stays safe and healthy during the COVID-19 pandemic! The entire AADAP staff is currently teleworking, so if you need to contact us, it's best to reach out via email. Thank you!
AADAP recently received FDA authorization to open the GnRH IIa INAD #13-345 for participation. GnRH IIa is a spawning hormone to aid in the spawning of female ictalurid catfish. DelTaq Fish Health LLC is the manufacturer for this INAD. Please see the GnRH lla web fact page for more information. The INAD is ready for enrollment through the online database. Please contact email@example.com for more information.
The 26th Annual Aquaculture Drug Approval Coordination Workshop is scheduled for July 27th-30th, 2020 in Bozeman, MT. Stay tuned to the AADAP website and monthly AADAP Updates for more details later this winter!
AADAP is on the lookout for facilities with the following conditions/species combinations in which to conduct efficacy studies:
If you know of any facilities with these conditions, please have them contact AADAP directly. Thank you!